Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis

International Journal of Oncology

Volumn 33, Issue 1, 2008, Pages 113-119

  Suzuki, Makoto ^a   Mohamed, Sherif ^a   Nakajima, Takahiro ^a   Kubo, Reiko ^a   Tian, Lei ^a   Fujiwara, Taiki ^a   Suzuki, Hidemi ^a   Nagato, Kaoru ^a   Chiyo, Masako ^a   Motohashi, Shinichiro ^a   Yasufuku, Kazuhiro ^a   Iyoda, Akira ^a   Yoshida, Shigetoshi ^a   Sekine, Yasuo ^a   Shibuya, Kiyoshi ^a   Hiroshima, Kenzo ^a   Nakatani, Yukio ^a   Yoshino, Ichiro ^a   Fujisawa, Takehiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

CXCL12; CXCR4; Lung cancer; Methylation; Prognosis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; ADULT; CHEMISTRY; DNA METHYLATION; GENETICS; LUNG TUMOR; MIDDLE AGED; MORTALITY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOKINE CXCL12; DNA METHYLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR4;

EID: 51049091703     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.33.1.113     Document Type: Article

References (22)

1. Winton T, Livingston R, Johnson D, et al: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Eng J Med 352: 2589-2597, 2005.
2. Kato H, Ichinose Y, Ohta M, et al: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma. of the lung. N Eng J Med 350: 1713-1721, 2004.
3. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M and Tanimoto M: Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 22: 3860-3867, 2004.
4. Iizasa T, Suzuki M, Yasufuku K, et al: Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma. Ann Thorac Surg 77: 1896-1903, 2004.
5. Wang J, Loberg R and Taichman RS: The pivotal role of CXCL12 (SDF-1)/ CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25: 573-587, 2006.
6. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Eng J Med 338: 436-445, 1998.
7. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Resp Crit Care Med 167: 1676-1686, 2003.
8. + T cells accumulate in lung adenocarcinoma. J Immunol 177: 6983-6990, 2006.
9. Begum NA, Coker A, Shibuta K, et al: Loss of hIRH mRNA expression from premalignant adenomas and malignant cell lines. Biochem Biophys Res Commun 1229: 864-868, 1996.
10. Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. New Eng J Med 349: 2042-2054, 2003.
11. Gazdar AF, Miyajima K, Reddy J, et al: Molecular targets for cancer therapy and prevention. Chest 125 (suppl 5): 97-101, 2004.
12. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V and Dwinell MB: Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 25: 4986-4997, 2006.
13. Suzuki M, Shigematsu H, Shames DS, et al: DNA methylation-associated inactivation of TGFbeta-related genes DRM/ Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer 93: 1029-1037, 2005.
14. Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF and Minna JD: RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 64: 3137-3143, 2004.
15. Suzuki M, Toyooka S, Miyajima K, et al: Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 9: 5636-5641, 2003.
16. Suzuki M, Shigematsu H, Iizasa T, et al: Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer 106: 2200-2207, 2006.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
18. Scala S, Ottaiano A, Ascierto PA, et al: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 11: 1835-1841, 2005.
19. Zagzag D, Krishnamachary B, Yee H, et al: Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of function induces expression of a ligand and its receptor. Cancer Res 65: 6179-6189, 2005.
20. Liotta LA: An attractive force in metastasis. Nature 410: 24-25, 2001.
21. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
22. Su L, Zhang J, Xu H, et al: Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin Cancer Res 11: 8273-8280, 2005.